Rehabilitation for speech after tongue cancer surgery using a prosthesis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a palatal augmentation prosthesis (PAP) in improving speech and swallowing functions in patients who have undergone surgery for T1/T2 tongue cancer. Patients will be randomly assigned to receive either the PAP or serve as a control group without the device. The study aims to fill a gap in current knowledge regarding post-surgical rehabilitation for oral cancer patients. Speech evaluations will be conducted using multiple scales to assess the impact of the PAP on communication abilities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with a new diagnosis of a T1/T2 tongue cancer

Exclusion Criteria:

* Patients with recurrent disease
* Patients with a history of prior head and neck radiation therapy
* Patients who lack adequate maxillary dentition to support a palatal augmentation prosthesis

Where it's running

• University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry
  Ann Arbor, Michigan, United States Recruiting

Study contacts

• Principal investigator: Stephanie M Munz, DDS — University of Michigan
• Study coordinator: Stephanie M Munz, DDS
• Email: smmunz@med.umich.edu
• Phone: 734 936-8289

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surgeon-performed ultrasound to guide real-time removal of oral cancer

  This will test whether surgeons using ultrasound during operations can more often remove oral cancers with clear margins in adults with T1–T3 oral squamous cell carcinoma.

  Recruiting at 3 sites Copenhagen University Hospital, Rigshospitalet · Stanford, California and 6 other locations · NCT07203911

• Intratumoral fluorescent nivolumab before surgery in head and neck cancer

  This study tests injecting fluorescently labeled nivolumab directly into head and neck tumors to see if it is safe and whether it reaches nearby lymph nodes before surgical removal.

  Recruiting Early Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07741565

• AI-assisted prehabilitation to help oral cancer patients return to work

  This trial will test an AI-assisted prehabilitation program to help adults with oral cancer reduce physical and emotional problems and return to work.

  Recruiting at 4 sites Taipei Veterans General Hospital, Taiwan · Taipei and 4 other locations · NCT07562100

• AI tool to measure jaw, neck, and shoulder movement for oral cancer care

  This project tests an AI system that automatically measures jaw, neck, and shoulder movement for people with or recovering from oral cancer and compares its readings to manual measurements.

  Recruiting National Taiwan University Hospital · Taipei · NCT07509619

• Dezocine versus nalbuphine with sufentanil for pain control after oral cancer surgery with free-flap reconstruction

  This will see if adding dezocine or nalbuphine to sufentanil reduces pain and complications for adults undergoing oral cancer surgery with free-flap reconstruction.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07401641

• Hydrogen water oral care after free flap reconstruction for oral cancer

  A randomized trial tests whether hydrogen water oral care helps reduce inflammation and pain and improve oral bacteria after surgery for oral cancer.

  Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung City · NCT07306546

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.